000 | 00933 a2200253 4500 | ||
---|---|---|---|
005 | 20250511182644.0 | ||
264 | 0 | _c19921106 | |
008 | 199211s 0 0 eng d | ||
022 | _a0090-3493 | ||
024 | 7 |
_a10.1097/00003246-199210000-00003 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPollack, M M | |
245 | 0 | 0 |
_aAn R.S.V.P. to R.S.V. (respiratory syncytial virus): declining mortality rates. _h[electronic resource] |
260 |
_bCritical care medicine _cOct 1992 |
||
300 |
_a1375-6 p. _bdigital |
||
500 | _aPublication Type: Comment; Editorial | ||
650 | 0 | 4 |
_aCritical Care _xstandards |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aRespiratory Syncytial Viruses |
650 | 0 | 4 |
_aRespirovirus Infections _xmortality |
650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
773 | 0 |
_tCritical care medicine _gvol. 20 _gno. 10 _gp. 1375-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00003246-199210000-00003 _zAvailable from publisher's website |
999 |
_c1402150 _d1402150 |